@WHO: WHO and @UNITAID welcome the signing of a voluntary licensing agreement by the @MedsPatentPool and MSD to facilitate affordable access to #molnupiravir, a new medicine being tested in clinical trials for treating #COVID19 in adults. More: https://t.co/ik4fdOUKhv

http://twitter.com/WHO
via IFTTT